Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel

被引：16

作者：

Andreadis, Charalambos ^{[1
]}

Tam, Constantine S. ^{[2
,3
]}

Borchmann, Peter ^{[4
,5
]}

Jaeger, Ulrich ^{[6
]}

McGuirk, Joseph P. ^{[7
]}

Holte, Harald ^{[8
]}

Waller, Edmund K. ^{[9
]}

Jaglowski, Samantha ^{[10
]}

Bishop, Michael R. ^{[11
]}

Foley, Stephen Ronan ^{[12
]}

Westin, Jason R. ^{[13
]}

Fleury, Isabelle ^{[14
,15
]}

Ho, P. Joy ^{[16
]}

Mielke, Stephan ^{[17
]}

Teshima, Takanori ^{[18
]}

Salles, Gilles A. ^{[19
]}

Schuster, Stephen J. ^{[20
]}

Bachanova, Veronika ^{[21
]}

Maziarz, Richard T. ^{[22
]}

Van Besien, Koen ^{[23
]}

Izutsu, Koji ^{[24
]}

Magenau, John M. ^{[25
]}

Wagner-Johnston, Nina D. ^{[26
,27
]}

Kato, Koji ^{[28
]}

Corradini, Paolo ^{[29
,30
]}

Tiwari, Ranjan ^{[31
]}

Awasthi, Rakesh ^{[32
]}

Lawniczek, Tomasz ^{[33
]}

Eldjerou, Lamis K. ^{[34
]}

Kersten, Marie Jose ^{[35
]}

机构：

[1] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[2] St Vincent Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[3] Univ Melbourne, Melbourne, Vic, Australia

[4] Univ Cologne, GHSG, Cologne, Germany

[5] Univ Cologne, Dept Internal Med 1, CIO ABCD, Cologne, Germany

[6] Med Univ Vienna, Dept Med 1, Clin Div Hematol & Hemostaseol, Vienna Gen Hosp, Vienna, Austria

[7] Univ Kansas Hlth Syst, Dept Internal Med, Kansas City, KS USA

[8] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[9] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[10] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA

[11] Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA

[12] Hamilton Hlth Sci, Hamilton, ON, Canada

[13] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[14] Maisonneuve Rosemont Hosp, Montreal, PQ, Canada

[15] Univ Montreal, Montreal, PQ, Canada

[16] Royal Prince Alfred Hosp, Inst Haematol, Dept Haematol, Camperdown, NSW, Australia

[17] Univ Wurzburg, Wurzburg Univ Med Ctr, Dept Internal Med 2, Ctr Allogene Stem Cell Transplantat, Wurzburg, Germany

[18] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[19] Lyon Sud Univ Hosp Complex, Pierre Benite, Pierre Benite, France

[20] Univ Penn, Abramson Canc Ctr, Lymphoma Grp, Philadelphia, PA 19104 USA

[21] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA

[22] Oregon Hlth & Sci Univ, Ctr Hematol Malignancies, Portland, OR 97201 USA

[23] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA

[24] Natl Canc Ctr, Dept Hematol, Tokyo, Japan

[25] Univ Michigan, Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA

[26] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA

[27] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[28] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka, Japan

[29] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[30] Univ Milan, Milan, Italy

[31] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India

[32] Novartis Inst BioMed Res, E Hanover, NJ USA

[33] Novartis Pharma AG, Basel, Switzerland

[34] Novartis Pharmaceut, E Hanover, NJ USA

[35] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124492

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2883

引用

页数：6